Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Otsuka
Otsuka
Drug makers face another $65 billion patent cliff
Marketwatch
Wed, 12/10/14 - 05:37 pm
patents
patent cliff
Pfizer
Otsuka
AstraZeneca
Bristol-Myers Squibb
Otsuka May Have Undervalued Avanir’s (AVNR) Bid; Shareholders Worried
Bidness Etc.
Fri, 12/5/14 - 11:01 am
Otsuka
M&A
Avanir
Japan’s Otsuka to buy U.S. drug maker Avanir for $3.5 billion
Fortune
Tue, 12/2/14 - 08:39 am
Otsuka
M&A
Avanir
Bristol-Myers, Otsuka ask judge to nix Abilify kickback suit
Fierce Pharma
Mon, 10/13/14 - 10:26 am
Bristol-Myers Squibb
Otsuka
kickbacks
Abilify
whistleblower lawsuits
TB Drug Fighting Resistant Strains Wins Europe Approval
Bloomberg
Wed, 04/30/14 - 08:59 am
TB
Europe
Otsuka
Deltyba
tuberculosis
Otsuka Pharmaceutical Completes Acquisition of Astex Pharmaceuticals
Pharmiweb
Sat, 10/12/13 - 12:02 pm
Otsuka
Astex
M&A
Lundbeck, Otsuka start trials for Alzheimer's drug
Reuters
Thu, 10/10/13 - 08:31 am
Otsuka
Lundbeck
Alzheimer's disease
Lu AE58054
Biotech Buyout Celebration or Raw Deal?
Motley Fool
Sat, 10/5/13 - 09:55 am
Astex
Otsuka
M&A
Astex Pharma shareholder opposes $886 mln bid by Otsuka
Yahoo/Reuters
Thu, 10/3/13 - 09:08 am
Astex
Otsuka
shareholders
M&A
CHMP thumbs up for 11 new drugs
Pharma Times, UK
Mon, 09/23/13 - 09:33 am
Europe
drug approvals
Kadcyla
Roche
Bayer
Xofigo
Abilify Maintena
Otsuka
Lundbeck
Memantine Accord
Accord Healthcare
Levodopa Carbidopa Entacapone Sandoz
Orion
Vitekta
Gilead
Janssen-Cilag
Invokana
Novo Nordisk
NovoEight
AstraZeneca
Fluenz Tetra
GSK
Relvar Ellipta
Lidocaine/Prilocaine Plethora
Plethora Solutions
Lundbeck, Otsuka get positive opinion for schizophrenia drug
Reuters
Fri, 09/20/13 - 09:42 am
Otsuka
Lundbeck
Europe
schizophrenia
Abilify Maintena
Astex Sued by Shareholder Over $886 Million Otsuka Bid
Bloomberg
Fri, 09/13/13 - 03:44 pm
Astex
shareholders
Otsuka
M&A
This Week in Biotech
Motley Fool
Sun, 09/8/13 - 11:09 am
Astex
Otsuka
Rockwell Medical
Theravance
GSK
Cytokinetics
Amgen
Japan's Otsuka to buy Astex Pharma for about $900 million
Reuters
Wed, 09/4/13 - 05:33 pm
Japan
M&A
Otsuka
Astex
Otsuka's tolvaptan gets priority review at FDA
Pharma Times, UK
Mon, 04/15/13 - 09:36 am
Tolvaptan
Otsuka
FDA
autosomal dominant polycystic kidney disease
Firm ranks top 5 biotech deals in evolving pharma R&D landscape
Fierce Biotech
Fri, 04/12/13 - 01:56 pm
biotech
M&A
Otsuka
Lundbeck
Gilead
Macrogenics
Roche
Chiasma
Edison Pharma
Dainippon
Moderna
AstraZeneca
Alzheimer's Drug Race Heats Up With Lundbeck Deal
Investors.com
Wed, 03/27/13 - 09:52 am
Lundbeck
Alzheimer's disease
Otsuka
Lu AE58054
Otsuka to Pay Lundbeck $825 Million for Alzheimer’s Drug
Bloomberg
Tue, 03/26/13 - 10:15 am
Otsuka
Alzheimer's disease
Lu AE58054
Otsuka, Lundbeck Win Approval for Monthly Abilify Shot
Bloomberg
Fri, 03/1/13 - 11:12 am
schizophrenia
Lundbeck
Otsuka
Abilify
Abilify Maintena
FDA warns of liver injury risk associated with hyponatremia drug
Healio
Sun, 01/27/13 - 11:33 am
hyponatremia
Samsca
Otsuka
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »